MedTrace Logo

Cognitive Recovery After Electroconvulsive Therapy and General Anesthesia

NCT02761330 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 17

Last updated 2021-06-28

Study results available
· View outcomes & findings →

Summary

This study is geared toward characterizing the recovery of brain activity and cognitive function following treatments of electroconvulsive therapy and ketamine general anesthesia.

Conditions

Interventions

DRUG

Ketamine

Ketamine will be used to induce general anesthesia with or without subsequent ECT. Within a single patient, the dose will remain consistent throughout the study and is estimated to be 2 mg/kg.

PROCEDURE

Electroconvulsive Therapy

Dose of the ECT charge will be determined during titration session prior to randomization.

Sponsors & Collaborators

  • James S McDonnell Foundation

    collaborator OTHER

  • Washington University School of Medicine

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-30
Primary Completion
2019-09-11
Completion
2019-09-11

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02761330 on ClinicalTrials.gov